RecallDepth
Class I Terminated

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
January 5, 2022
Posted
January 26, 2022
Recall Number
D-0462-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
73,175 prefilled pens
Firm Location
Morgantown, WV, United States

Reason for Recall

Labeling: Missing Label: label missing from some Semglee prefilled pens.

Distribution

Nationwide in the USA and Thailand.

Lot / Code Info

Batch # BF20003118, Exp. August 2022

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class I Drug recalls